Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2020 AACR Virtual Special Conference: Pancreatic Cancer
ESMO Virtual Congress 2020
2020 ASCO Quality Care Symposium
2020 SSO International Conference on Surgical Cancer Care
12th European Breast Cancer Conference
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Roundtable:
Lymphoma/Myeloma
Roundtable:
Lung Cancer
Podcasts
CME
Methotrexate–Induced Kidney Injury
Advertisement
Advertisement
Op-Ed
Advertisement
Advertisement
Oct
26
Today In Oncology
FDA Approves Remdesivir for Patients With COVID-19 Requiring Hospitalization
FDA Pipeline Priority Reviews in EGFR-Mutant Lung Cancer, Advanced Renal Cell Carcinoma; Fast Track Designations in CLL and Solid Tumors
Addition of Atezolizumab to Neoadjuvant Chemotherapy in Early-Stage Triple-Negative Breast Cancer
First-Line Durvalumab With or Without Tremelimumab vs Chemotherapy for Metastatic Urothelial Carcinoma
Novel Small-Molecule Inhibitor Surufatinib for Advanced Extrapancreatic Neuroendocrine Tumors
View More
Advertisement
